← Back to catalogue

Rabs

FDA UDI

Class I (US FDA UDI)

by Randox Laboratories, Ltd.

Identity

Trade Name
RABS FDA UDI
Generic Name
Optical laboratory instrument performance standard calibrator/control IVD, single-use FDA UDI
Device Name
The Reagent Precision Test is used on the RX series clinical chemistry systems for checking proper functioning of the reagent fluid metering and photometric measuring system. FDA UDI
Model / Reference
RP8398 FDA UDI
Description
The Reagent Precision Test is used on the RX series clinical chemistry systems for checking proper functioning of the reagent fluid metering and photometric measuring system. FDA UDI

Identifiers

Catalog Number
RP8398 FDA UDI
Primary DI / UDI-DI
05055273214307 FDA UDI
FDA Product Code
JJE FDA UDI
GMDN Term
Optical laboratory instrument performance standard calibrator/control IVD, single-use FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.2160 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Optical laboratory instrument performance standard calibrator/control IVD, single-use

Rabs by Randox Laboratories, Ltd. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Optical laboratory instrument performance standard calibrator/control IVD, single-use.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI f2d15d2b-ed4b-445a-8d60-6eff824b5a88 36 fields · synced May 30, 2026